Regeneron Pharmaceuticals Market Sentiment

Regeneron Pharmaceuticals Inc

REGNNASDAQ

Trade with Public

$799.08

4.890.62%

al cierre: Aug 31, 5:00 PM EST

$800.23

1.150.14%

After hour: 6:48 PM EST

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Dividendos Comparar Opciones Informe de acciones

Regeneron Pharmaceuticals Market Sentiment

Market sentiment signals for Regeneron Pharmaceuticals (REGN): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 2.5% short float

Options Flow▲ 0.35 P/C ratio

Insider Activity— Neutral (30d)

Analyst Consensus

Buy

31 analysts

Options Flow (P/C)

0.35

More calls — Bullish

567 calls · 201 puts

Avg Consensus PT

$797

-0.5%

Highest Price Target

$1030

+28.7%

Guggenheim

Lowest Price Target

$185

-76.9%

Benchmark

Short Interest

2.5%

Declining — Bullish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 17, 2026	Leerink Partners	David Risinger—	+3.0%	$641 → $824	Maintained	Market Perform
Aug 3, 2026	Citigroup	Geoff Meacham—	-7.5%	$700 → $740	Maintained	Neutral
Aug 3, 2026	Guggenheim	Brad Canino—	+28.7%	$1000 → $1030	Maintained	Buy
Jul 31, 2026	RBC Capital	Brian Abrahams—	-7.9%	$696 → $737	Maintained	Sector Perform
Jul 31, 2026	Morgan Stanley	Matthew Harrison—	-5.3%	$730 → $758	Maintained	Equal-Weight
Jul 31, 2026	Cantor Fitzgerald	Carter Gould—	-0.7%	$750 → $795	Maintained	Overweight
Jul 31, 2026	Wells Fargo	Mohit Bansal—	-6.3%	$700 → $750	Maintained	Equal-Weight
Jul 31, 2026	Truist Securities	Gregory Renza—	-3.5%	$769 → $772	Maintained	Buy
Jul 21, 2026	Guggenheim	Brad Canino—	+25.0%	$995 → $1000	Maintained	Buy
Jul 9, 2026	Piper Sandler	Biren Amin—	+6.7%	$855 → $854	Maintained	Overweight
Jul 8, 2026	Morgan Stanley	Matthew Harrison—	-8.8%	$788 → $730	Maintained	Equal-Weight
Jul 7, 2026	RBC Capital	Brian Abrahams—	-13.0%	$707 → $696	Maintained	Sector Perform
Jul 7, 2026	Truist Securities	Gregory Renza—	-3.9%	$778 → $769	Maintained	Buy
Jul 7, 2026	Benchmark	Robert Wasserman—	-76.9%	$185	Upgrade	Hold→Buy
Jul 6, 2026	HSBC	Rajesh Kumar—	+10.0%	$990 → $880	Maintained	Buy
Jul 6, 2026	Cantor Fitzgerald	Carter Gould—	-6.3%	$785 → $750	Maintained	Overweight
May 19, 2026	Canaccord Genuity	John Newman—	+9.3%	$1057 → $875	Maintained	Buy
May 18, 2026	BMO Capital	Evan David Seigerman—	-8.8%	$900 → $730	Maintained	Outperform
May 18, 2026	Truist Securities	Gregory Renza—	-2.8%	$796 → $778	Maintained	Buy
May 18, 2026	JP Morgan	Chris Schott—	+6.2%	$950 → $850	Maintained	Overweight
May 18, 2026	Piper Sandler	Biren Amin—	+6.8%	$875 → $855	Maintained	Overweight
May 18, 2026	Wells Fargo	Mohit Bansal—	-12.5%	$800 → $700	Maintained	Equal-Weight
May 18, 2026	RBC Capital	Brian Abrahams—	-11.7%	$762 → $707	Maintained	Sector Perform
May 18, 2026	Citigroup	Geoff Meacham—	-12.5%	$900 → $700	Downgrade	Buy→Neutral
May 18, 2026	Leerink Partners	Andrew Berens—	-19.9%	$792 → $641	Downgrade	Outperform→Market Perform